Pharmaconic

The vendor opportunity at Pharmaconic

Pharmaconic is a personal-services pharmacy franchise based in New York, with a total footprint of just 3 units—1 franchised location and 2 company-owned stores. The franchisor is independently owned, with no parent company on file. For software vendors, the immediate addressable market is the single franchised unit, though the two company-owned locations may also fall under the same centralized technology decisions. The 2024 FDD does not disclose average unit volume (AUV) or year-over-year unit growth, so sizing the long-term pipeline is difficult. However, the franchise’s initial term of 10 years and a modest 3.0% royalty suggest a stable, if small, operating model.

Who controls software purchasing

All signs point to headquarters-level control. The FDD lists Stanislav Zavulunov, R.Ph as President, and no other executives or multi-unit operators are named in our corpus. In a system this small, the President typically serves as the de facto technology buyer. Vendors should direct all outreach to Mr. Zavulunov, framing solutions around pharmacy workflow efficiency and compliance, given his pharmacist background. There is no CIO, CTO, or VP of IT disclosed, so the buying center is effectively a single person.

Mandated and current tech stack

Pharmaconic mandates two specific systems: PrimePOS for point-of-sale and PrimeRx for pharmacy management. These are named in the FDD as required technology, meaning franchisees have no discretion to choose alternatives. For vendors selling competing POS or pharmacy management platforms, the opportunity is essentially zero unless the franchisor decides to switch mandated providers. Adjacent software categories—such as inventory management, patient engagement, or compliance tools—may have a path in if they integrate with PrimeRx and PrimePOS. No other mandated or recommended vendors are disclosed.

Procurement, renewals, and timing

The FDD does not include an Item 8 extract, so the formal procurement model is unknown. It is unclear whether Pharmaconic uses designated suppliers, an approved supplier list, or an open procurement process. Vendors will need to inquire directly about how to become an approved vendor. On renewals, Item 17 outlines a 10-year successor term, contingent on good standing, no more than three defaults, six months’ written notice, a successor agreement fee, and execution of a general release. The franchisor also reserves the right to impose materially different terms in the new agreement. This creates a potential window for technology re-evaluation at each renewal, though with only one franchised unit, the cadence is sparse.

How to read the Pharmaconic FDD

The 2024 Pharmaconic Franchise Disclosure Document is embedded below. It was filed with state franchise regulators and contains the full legal and operational details vendors need to assess fit. Key sections for software sales planning include Item 11 (mandated systems), Item 1 (executive team), Item 8 (procurement restrictions), and Item 17 (renewal and transfer conditions). Because the system is so small, the FDD is the single best source of truth on who decides, what is required, and when contracts open. For a ranked target list of franchise systems that match your software category, reach out to FranCloud.